41 – 50 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer
(
- Contribution to journal › Article
-
Mark
Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates
(
- Contribution to journal › Scientific review
-
Mark
Receptor-induced phasic activity of newborn mouse bladders is inhibited by protein kinase C and involves T-type Ca channels.
(
- Contribution to journal › Article
-
Mark
Treatment of prostate cancer with hormonal therapy in Europe
(
- Contribution to journal › Article
-
Mark
Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study
(
- Contribution to journal › Article
-
Mark
Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder.
(
- Contribution to journal › Article
-
Mark
Optimal management of metastatic renal cell carcinoma: an algorithm for treatment.
(
- Contribution to journal › Article
-
Mark
THE CONTINUING ROLE OF PROSTATE-SPECIFIC ANTIGEN AS A MARKER FOR LOCALIZED PROSTATE CANCER: 'DO NOT THROW THE BABY OUT WITH THE BATH WATER'
(
- Contribution to journal › Article
-
Mark
Signal transduction pathways of muscarinic receptor mediated activation in the newborn and adult mouse urinary bladder.
(
- Contribution to journal › Article
-
Mark
The developing role of hormonal therapy in the treatment of prostate cancer.
(
- Contribution to journal › Article